Breast Cancer Now media statements
Responding to new research into the impact of dairy on breast cancer risk
Dr Kotryna Temcinaite, Senior Research Communications Manager at Breast Cancer Now, said:
We respond to NHS England breast cancer waiting times: September 2021
Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said:
We respond to new guidelines for the treatment of secondary breast cancer agreed at the Advanced Breast Cancer Sixth International Consensus Conference (ABC 6)
Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said new guidelines for the treatment of secondary breast cancer agreed at the...
We respond to new survey results from the ABC6 Conference titled “Advanced breast cancer patients denied opportunities to join clinical trials. Patient advocate calls for collaboration to improve access to trials”
Dr Simon Vincent, Director of Research, Support and Influencing at Breast Cancer Now, said:
We respond to new research titled “Major global study reveals risk of breast cancer spreading to other parts of the body"
Dr Kotryna Temcinaite, Senior Research Communications Manager at Breast Cancer Now, responded to new research presented at the Advanced Brea...
We respond to draft NICE decision to not recommend tucatinib with trastuzumab and capecitabine for routine use on the NHS
The National Institute for Health and Care Excellence (NICE) has today (Tuesday 26 October 2021) announced its provisional decision to not r...
We respond to Macmillan Cancer Support's warning of 'perfect storm' of Covid and staff shortages
Mia Rosenblatt, Associate Director of Policy, Evidence and Influencing at Breast Cancer Now, said:
We respond to a new study into eating nuts and breast cancer recurrence
Dr Kotryna Temcinaite, Senior Research Communications Manager at Breast Cancer Now, said:
We respond to a report from the IPPR and CF suggesting it could take over a decade to clear the cancer treatment backlog in England
Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said:
We respond to new data for Enhertu presented at the European Society for Medical Oncology conference
Dr Kotryna Temcinaite, Senior Research Communications Manager at Breast Cancer Now, said:
We respond to news of NHS England and Amgen reaching a national agreement to enable early access to Sotorasib for eligible lung cancer patients in England
Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said:
We respond to Macmillan Cancer Support's new research revealing severe nurse shortages are putting cancer patients at risk
Dr Simon Vincent, Director of Research, Support and Influencing at Breast Cancer Now, said: